Mostrar el registro sencillo del ítem

dc.contributor.author
Menendez, Javier A.  
dc.contributor.author
Benboudjema, Louisa  
dc.contributor.author
Vellón, Luciano  
dc.contributor.author
Rubio, Miguel A.  
dc.contributor.author
Espinoza, Ingrid  
dc.contributor.author
Campisi, Judith  
dc.contributor.author
Lupu, Ruth  
dc.date.available
2016-10-19T18:28:57Z  
dc.date.issued
2015-07-22  
dc.identifier.citation
Menendez, Javier A.; Benboudjema, Louisa; Vellón, Luciano; Rubio, Miguel A.; Espinoza, Ingrid; et al.; Heregulin, a new interactor of the telosome/shelterin complex in human telomeres; Impact Journals; Oncotarget; 6; 37; 22-7-2015; 39408-39421  
dc.identifier.issn
1949-2553  
dc.identifier.uri
http://hdl.handle.net/11336/7739  
dc.description.abstract
Telomere length, shape and function depend on a complex of six core telomere-associated proteins referred to as the telosome or shelterin complex. We here demonstrate that the isoform beta2 of the heregulin family of growth factors (HRGbeta2) is a novel interactor of the telosome/shelterin complex in human telomeres. Analysis of protein-protein interactions using a high-throughput yeast two-hybrid (Y2H) screen identified RAP1, the only telomere protein that is conserved from yeasts to mammals, as a novel interacting partner of HRGbeta2. Deletion analysis of RAP1 revealed that the linker domain, a region previously suggested to recruit negative regulators of telomere length, interacts specifically with HRGbeta2. Co-immunoprecipitation and imaging experiments demonstrated that, in addition to RAP1, HRGβ2 could associate with the RAP1-associated telomeric repeat binding factor 2 (TRF2). Deletion analysis of HRGβ2 confirmed that a putative nuclear localization signal (NLS) was necessary for nuclear HRGbeta2 to exert a negative regulation of telomere length whereas the N-terminus (extracellular) amino acids of HRGbeta2 were sufficient to interact with RAP1/TRF2 and promote telomere shortening. Taken together, our studies identify nuclear HRGbeta2 as one of the previously unknown regulators predicted to be recruited by the RAP1 linker domain to negatively regulate telomere length in human cells. Our current findings reveal that a new, but likely not the last, unexpected visitor has arrived to the "telosome/shelterin town".  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Impact Journals  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Trf2  
dc.subject
Heregulin  
dc.subject
Sheltering Complex  
dc.subject
Telomere  
dc.subject
Telosome  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Heregulin, a new interactor of the telosome/shelterin complex in human telomeres  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-10-04T19:27:15Z  
dc.identifier.eissn
1949-2553  
dc.journal.volume
6  
dc.journal.number
37  
dc.journal.pagination
39408-39421  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Nueva York  
dc.description.fil
Fil: Menendez, Javier A.. Catalan Institute of Oncology; España. Girona Biomedical Research Institute; España  
dc.description.fil
Fil: Benboudjema, Louisa. Evanston Northwestern Healthcare Research Institute; Estados Unidos  
dc.description.fil
Fil: Vellón, Luciano. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina  
dc.description.fil
Fil: Rubio, Miguel A.. Hospital de la Santa Creu i Sant Pau. Institut d’Investigació Biomèdica Sant Pau,; España  
dc.description.fil
Fil: Espinoza, Ingrid. University Of Mississippi; Estados Unidos. Lawrence Berkeley National Laboratory; Estados Unidos  
dc.description.fil
Fil: Campisi, Judith. Lawrence Berkeley National Laboratory; Estados Unidos. Buck Institute for Research on Aging; Estados Unidos  
dc.description.fil
Fil: Lupu, Ruth. Mayo Clinic Cancer Center; Estados Unidos. Mayo Clinic. Department of Laboratory Medicine and Pathology; Estados Unidos  
dc.journal.title
Oncotarget  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741835/  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.18632/oncotarget.4962  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=4962&pubmed-linkout=1